Literature DB >> 6741972

Our appropriate concern about hypokalemia.

N M Kaplan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6741972     DOI: 10.1016/0002-9343(84)90427-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  17 in total

1.  Potassium and the anaesthetist.

Authors:  T Vitez
Journal:  Can J Anaesth       Date:  1987-05       Impact factor: 5.063

Review 2.  Reserpine: a relic from the past or a neglected drug of the present for achieving cost containment in treating hypertension?

Authors:  G J Magarian
Journal:  J Gen Intern Med       Date:  1991 Nov-Dec       Impact factor: 5.128

Review 3.  Thiazide effects and adverse effects: insights from molecular genetics.

Authors:  David H Ellison; Johannes Loffing
Journal:  Hypertension       Date:  2009-06-29       Impact factor: 10.190

4.  Guidelines for reading literature reviews.

Authors:  A D Oxman; G H Guyatt
Journal:  CMAJ       Date:  1988-04-15       Impact factor: 8.262

Review 5.  The elderly patient. A special case for diuretic therapy.

Authors:  D E Hyams
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 6.  Diuretic drugs. Progress in clinical pharmacology.

Authors:  A Lant
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 7.  Potassium and anaesthesia.

Authors:  J E Tetzlaff; J F O'Hara; M T Walsh
Journal:  Can J Anaesth       Date:  1993-03       Impact factor: 5.063

8.  Diuretics, potassium and arrhythmias in hypertensive coronary disease.

Authors:  H Ikram; E A Espiner; M G Nicholls
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 9.  Diuretic therapy and exercise performance.

Authors:  J E Caldwell
Journal:  Sports Med       Date:  1987 Jul-Aug       Impact factor: 11.136

10.  Swiss hypertension treatment programme with verapamil and/or enalapril in diabetic patients.

Authors:  C Ferrier; P Ferrari; P Weidmann; U Keller; C Beretta-Piccoli; W F Riesen
Journal:  Drugs       Date:  1992       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.